abrdn Life Sciences director files Form 3

abrdn Life Sciences Investors director Mahai Chris LaVictoire has filed an initial Form 3, which is a required statement of beneficial ownership for new insiders.

Rhea-AI Filing Summary

abrdn Life Sciences Investors director Mahai Chris LaVictoire has filed an initial Form 3, which is a required statement of beneficial ownership for new insiders. The filing shows no reportable transactions or holdings, indicating no beneficial ownership entries at the time of this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the HQL Form 3 filed by Mahai Chris LaVictoire show?

The Form 3 for HQL shows that director Mahai Chris LaVictoire reported no transactions or holdings. A Form 3 is an initial statement of beneficial ownership required when someone becomes an insider of a public company.

Did Mahai Chris LaVictoire buy or sell any HQL shares in this Form 3?

No, the Form 3 shows no purchases, sales, or other transactions in HQL shares. All transaction counts and share amounts, including buy, sell, exercise, and gifts, are reported as zero in the filing’s transaction summary.

Does the HQL Form 3 show any derivatives or options held by Mahai Chris LaVictoire?

No, the Form 3 lists no derivative positions such as options or warrants. The derivative summary is empty and derivativeTransactionCount is zero, indicating no reportable derivative securities are shown in this initial ownership statement.

What is the purpose of the Form 3 filed for abrdn Life Sciences Investors (HQL)?

The Form 3 serves as an initial disclosure of an insider’s beneficial ownership in HQL. It is required when someone becomes a director, officer, or large shareholder, even if they currently report no shares or derivative securities.

Does the HQL Form 3 indicate any gifts, tax withholding, or restructuring transactions?

No, the filing reports zero gifts, zero tax-withholding dispositions, and zero restructuring transactions. The transactionSummary fields for gifts, tax withholding, and restructuring all show counts and share amounts of zero for this insider.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 11:32 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mahai Chris LaVictoire

(Last) (First) (Middle)

C/O ABRDN

1900 MARKET STREET, SUITE 200

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/09/2026

3. Issuer Name and Ticker or Trading Symbol
abrdn Life Sciences Investors [ HQL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Robert Stieger by POA from Reporting Person	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)